Go to Top


Avis aux professionnels de la santé concernant le risque d’interactions médicamenteuses entre Paxlovid et les anticoagulants

Les professionnels de la santé doivent savoir qu’il existe un risque d’interactions médicamenteuses entre les anticoagulants oraux directs (AOD) et un ingrédient de Paxlovid (le ritonavir) chez les patients traités Read More

Alert to Health Care Professionals about a potential drug-drug interaction between Paxlovid and anticoagulants

In patients who are receiving a direct oral anticoagulant (DOAC), especially apixaban and rivaroxaban, and may be eligible to receive the antiviral drug Paxlovid for the treatment of COVID-19, health Read More

TC Updated Statement March 18

THROMBOSIS CANADA UPDATED STATEMENT ON ASTRAZENECA VACCINE AND BLOOD CLOTS  Thrombosis Canada seeks to reassure the public regarding blood clot risk and COVID-19 vaccines  Toronto, Ontario (March 18, 2021) – Read More

%d bloggers like this: